Pretreatment of umbilical cord derived MSCs with IFN-γ and TNF-α enhances the tumor-suppressive effect on acute myeloid leukemia

CAR-T treatment of pediatric AML: a long and winding road

(2021) Barbara De Moerloose   BLOOD

Mesenchymal stem cells and cancer therapy: insights into targeting the tumour vasculature

(2021) Surendar Aravindhan et al.   Cancer Cell International

Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer

(2021) Jeremy J. McGuire et al.   Nature Communications

Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia

(2021) Francesco Paolo Tambaro et al.   LEUKEMIA

An overview of mesenchymal stem cells and their potential therapeutic benefits in cancer therapy (Review)

(2021) Shern Lim et al.   Oncology Letters

Preconditioned Mesenchymal Stromal Cells to Improve Allotransplantation Outcome

(2021) Hui-Yun Cheng et al.   Cells

Mesenchymal stem cell-derived exosome: A tumor regulator and carrier for targeted tumor therapy

(2021) Fusheng Zhang et al.   CANCER LETTERS

The safety of MSC therapy over the past 15 years: a meta-analysis

(2021) Yang Wang et al.   Stem Cell Research & Therapy

The safety and efficacy of mesenchymal stem cell therapy in diabetic lower extremity vascular disease: a meta-analysis and systematic review

(2021) Lewei Jin et al.   CYTOTHERAPY

Next-generation stem cells — ushering in a new era of cell-based therapies

(2020) Erin A. Kimbrel et al.   NATURE REVIEWS DRUG DISCOVERY

CAR T Cells for Acute Myeloid Leukemia: State of the Art and Future Directions

(2020) Sherly Mardiana et al.   Frontiers in Oncology

B7-H3 augments the pro-angiogenic function of tumor-associated macrophages and acts as a novel adjuvant target for triple-negative breast cancer therapy

(2020) Nan Cheng et al.   BIOCHEMICAL PHARMACOLOGY

Chimeric Antigen Receptor T-Cells in B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions

(2020) Uri Greenbaum et al.   Frontiers in Oncology

Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: Prevention, Detection, and Treatment

(2019) Christina Rautenberg et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Mesenchymal stem cells inhibit T-cell function through conserved induction of cellular stress

(2019) Adam G. Laing et al.   PLoS One

Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges

(2019) Myoung Woo Lee et al.   LEUKEMIA

Chimeric antigen receptor T-cell therapy for acute myeloid leukemia: how close to reality?

(2019) Katherine D. Cummins et al.   HAEMATOLOGICA

The mesenchymal stem cell secretome as an acellular regenerative therapy for liver disease

(2019) Julia Driscoll et al.   JOURNAL OF GASTROENTEROLOGY

The future of mesenchymal stem cell-based therapeutic approaches for cancer – From cells to ghosts

(2018) Andrea Mohr et al.   CANCER LETTERS

IFN-γ and TNF-α Pre-licensing Protects Mesenchymal Stromal Cells from the Pro-inflammatory Effects of Palmitate

(2018) Lauren Boland et al.   MOLECULAR THERAPY

Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment

(2018) Daria S. Chulpanova et al.   Frontiers in Pharmacology

Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors

(2018) Asha Nayak-Kapoor et al.   Journal for ImmunoTherapy of Cancer

Exosomal miR-146a Contributes to the Enhanced Therapeutic Efficacy of Interleukin-1β-Primed Mesenchymal Stem Cells Against Sepsis

(2017) Yuxian Song et al.   STEM CELLS

Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton’s jelly and bone marrow-derived mesenchymal stem cells

(2017) Aristea K. Batsali et al.   Stem Cell Research & Therapy

Transcriptome Profiling of IL-17A Preactivated Mesenchymal Stem Cells: A Comparative Study to Unmodified and IFN-γ Modified Mesenchymal Stem Cells

(2017) Kisha Nandini Sivanathan et al.   Stem Cells International

A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer

(2016) Oren Levy et al.   BIOMATERIALS

Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT

(2016) P Tsirigotis et al.   BONE MARROW TRANSPLANTATION

Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia

(2016) David B. Sykes et al.   CELL

Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse

(2016) Adam Nowakowski et al.   STEM CELLS AND DEVELOPMENT

Human lung-derived mesenchymal stem cell-conditioned medium exerts in vitro antitumor effects in malignant pleural mesothelioma cell lines

(2016) Lourdes Cortes-Dericks et al.   Stem Cell Research & Therapy

Characterization of menstrual stem cells: angiogenic effect, migration and hematopoietic stem cell support in comparison with bone marrow mesenchymal stem cells

(2015) Francisca Alcayaga-Miranda et al.   Stem Cell Research & Therapy

Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

(2014) J. M. Middeke et al.   BLOOD

Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells

(2014) S. Gill et al.   BLOOD

Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation

(2014) L Crucitti et al.   LEUKEMIA

Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects

(2013) R Yu et al.   Cell Death & Disease

Resistance to TRAIL in non-transformed cells is due to multiple redundant pathways

(2013) M van Dijk et al.   Cell Death & Disease

Comparative Evaluation of Human Mesenchymal Stem Cells of Fetal (Wharton's Jelly) and Adult (Adipose Tissue) Origin during ProlongedIn VitroExpansion: Considerations for Cytotherapy

(2013) I. Christodoulou et al.   Stem Cells International

Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSC) inhibit the proliferation of K562 (human erythromyeloblastoid leukaemic cell line)

(2012) Malini Fonseka et al.   CELL BIOLOGY INTERNATIONAL

Preactivation of Human MSCs with TNF-α Enhances Tumor-Suppressive Activity

(2012) Ryang Hwa Lee et al.   Cell Stem Cell

TNFα Cooperates with IFN-γ to Repress Bcl-xL Expression to Sensitize Metastatic Colon Carcinoma Cells to TRAIL-mediated Apoptosis

(2011) Feiyan Liu et al.   PLoS One

Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome

(2010) Amit Lahoti et al.   CANCER

Relapse after allogeneic stem cell transplantation

(2010) A John Barrett et al.   Expert Review of Hematology

Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach

(2009) J. M. Bennett et al.   HAEMATOLOGICA

Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1

(2009) Y Zhu et al.   LEUKEMIA

Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling

(2008) Ling Qiao et al.   CANCER LETTERS

Efficient Homing of Multipotent Adult Mesenchymal Stem Cells Depends on FROUNT-Mediated Clustering of CCR2

(2008) Fikru Belema-Bedada et al.   Cell Stem Cell

Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia

(2008) J.-V. Malfuson et al.   HAEMATOLOGICA

Effects of human bone marrow stromal cell line (HFCL) on the proliferation, differentiation and apoptosis of acute myeloid leukemia cell lines U937, HL-60 and HL-60/VCR

(2008) Rong Liang et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY